Rion Co., Ltd.
¥3,055-¥185 (-5.71%)
Rion Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.56% below the high.
JPX · 4671.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
FALCO HOLDINGS Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 8.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
FALCO HOLDINGS Co., Ltd.’s forward annual dividend is ¥128 per share, paid semi-annual. The forward yield is 4.72% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
FALCO HOLDINGS Co., Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow FALCO HOLDINGS Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥3,055-¥185 (-5.71%)
Rion Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.56% below the high.
¥1,212¥0 (0.0%)
Saint-Care Holding Corporation’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
¥192-¥8 (-4.0%)
CYBERDYNE Inc.’s quoted price sits in the lower half of its reported 52-week range, 54.29% below the high.
¥491+¥4 (+0.82%)
Kanamic Network Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 15.78% below the high.
¥758+¥67 (+9.7%)
CUC Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.68% below the high.
¥856+¥8 (+0.94%)
FINDEX Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.33% below the high.
¥635-¥1 (-0.16%)
Pharma Foods International Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.12% below the high.
¥737+¥6 (+0.82%)
Medius Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.